W Binder1, R Menapace, W Seitz
1Universitätsklinik für Strahlentherapie und Strahlenbiologie Wien, Osterreich.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Investigating Ruthenium-106 (Ru-106) CCB applicators revealed that the effective tumor treatment area is 20-25% smaller than anticipated. One applicator exhibited significant dose inhomogeneity, up to 40%.
Area of Science:
Context:
Purpose:
Summary:
Impact: